Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherRevenue (Gross)Shares IssuedShares OutstandingShares Outstanding
Ratios

Abeona Therapeutics (ABEO) Cost of Revenue (2020 - 2025)

Abeona Therapeutics has reported Cost of Revenue over the past 8 years, most recently at $1.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue changed N/A year-over-year to $1.0 million; the TTM value through Dec 2025 reached $1.6 million, changed N/A, while the annual FY2025 figure was $1.5 million, N/A changed from the prior year.
  • Cost of Revenue for Q4 2025 was $1.0 million at Abeona Therapeutics, up from $488000.0 in the prior quarter.
  • Over five years, Cost of Revenue peaked at $32.9 million in Q1 2021 and troughed at $30000.0 in Q3 2023.
  • A 4-year average of $4.6 million and a median of $419000.0 in 2022 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: changed 0.0% in 2021 and later surged 350.0% in 2023.
  • Year by year, Cost of Revenue stood at $32.9 million in 2021, then tumbled by 99.7% to $100000.0 in 2022, then crashed by 70.0% to $30000.0 in 2023, then surged by 3380.0% to $1.0 million in 2025.
  • Business Quant data shows Cost of Revenue for ABEO at $1.0 million in Q4 2025, $488000.0 in Q3 2025, and $100000.0 in Q2 2025.